Illumina
ILMN
$0.92 (-0.69%)
1D
1W
3M
1Y
5Y
ALL
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Accesswire • 2 days ago • ILMN
GRAIL INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 8 days ago • ILMN
GRAIL INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmThe Motley Fool • 14 days ago • ILMN
Is the Worst Over for Illumina Stock?CNBC • 15 days ago • ILMN
Carl Icahn says new Illumina CEO has his 'full support' months after proxy fightInvestopedia • 17 days ago • ILMN
Illumina Picks New CEO, but Shares Continue To SlideCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.